Cargando…

Discovery and characterization of an immunogenic neoantigen in a patient with metastatic triple negative breast cancer

Detalles Bibliográficos
Autores principales:	Assadipour, Yasmine, Goff, Stephanie, Crystal, Jessica S, Prickett, Todd D, Gartner, Jared J, Somerville, Robert, Xu, Hui, Black, Mary, Kriley, Isaac, Robbins, Paul F, Rosenberg, Steven A, Feldman, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649554/ http://dx.doi.org/10.1186/2051-1426-3-S2-P284

Ejemplares similares

Unique neoantigens expressed by melanomas and common epithelial cancers presented by multiple HLA alleles can be efficiently identified utilizing peptide prediction algorithms
por: Trebska-Mcgowan, Kasia, et al.
Publicado: (2015)

Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma
por: Leko, Vid, et al.
Publicado: (2021)

Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing
por: Lu, Yong-Chen, et al.
Publicado: (2021)

Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
por: Hanada, Ken-ichi, et al.
Publicado: (2015)

Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens
por: Parikh, Anup Y., et al.
Publicado: (2023)

Identification of mutation-specific tumor infiltrating lymphocytes from metastatic ovarian cancer
por: Deniger, Drew C, et al.
Publicado: (2015)

Immunotherapy generates selective pressure for acquisition of immunogenic neoantigens in escape tumors
por: Pan, Jenny H, et al.
Publicado: (2015)

Durable complete response in a patient with metastatic melanoma following adoptive transfer of autologous T cells recognizing 10 mutated tumor antigens
por: Prickett, Todd D, et al.
Publicado: (2015)

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
por: Aparicio, Belén, et al.
Publicado: (2022)

Diversity of mutated antigen recognition by tumor infiltrating lymphocytes from patients with metastatic melanoma
por: Crystal, Jessica S, et al.
Publicado: (2015)

Structure Based Prediction of Neoantigen Immunogenicity
por: Riley, Timothy P., et al.
Publicado: (2019)

Molecular mechanism of phosphopeptide neoantigen immunogenicity
por: Patskovsky, Yury, et al.
Publicado: (2023)

Cell surface marker-based capture of neoantigen-reactive CD8(+) T-cell receptors from metastatic tumor digests
por: Chatani, Praveen D, et al.
Publicado: (2023)

Cancer neoantigens and immunogenicity: mutation position matters
por: Capietto, Aude-Hélène, et al.
Publicado: (2020)

Use of CD137 up-regulation to identify T cell receptors specifically reactive with mutated tumor associated antigens from tumor infiltrating lymphocytes
por: Parkhurst, Maria, et al.
Publicado: (2015)

Specific recognition of an FGFR2 fusion by tumor infiltrating lymphocytes from a patient with metastatic cholangiocarcinoma
por: White, Bradley Sinclair, et al.
Publicado: (2023)

Pre‐existing heterologous T‐cell immunity and neoantigen immunogenicity
por: Leng, Qibin, et al.
Publicado: (2020)

3348 Structural Determinants of Neoantigen Immunogenicity for Cancer Therapy
por: Devlin, Jason, et al.
Publicado: (2019)

DeepNeo: a webserver for predicting immunogenic neoantigens
por: Kim, Jeong Yeon, et al.
Publicado: (2023)

Author Correction: Molecular mechanism of phosphopeptide neoantigen immunogenicity
por: Patskovsky, Yury, et al.
Publicado: (2023)

Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
por: Gros, Alena, et al.
Publicado: (2015)

Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
por: Zhang, Rui, et al.
Publicado: (2019)

Study and characterization of mutated antigen specific T cells isolated from fresh tumor and peripheral lymphocytes in cancer patients
por: Cohen, Cyrille, et al.
Publicado: (2015)

Immunogenic neoantigens derived from gene fusions stimulate T cell responses
por: Yang, Wei, et al.
Publicado: (2019)

Unraveling tumor specific neoantigen immunogenicity prediction: a comprehensive analysis
por: Nibeyro, Guadalupe, et al.
Publicado: (2023)

Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor–Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors
por: Kim, Sanghyun P., et al.
Publicado: (2022)

Seq2Neo: A Comprehensive Pipeline for Cancer Neoantigen Immunogenicity Prediction
por: Diao, Kaixuan, et al.
Publicado: (2022)

Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity
por: Mariuzza, Roy A., et al.
Publicado: (2023)

Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
por: Löffler, Markus W., et al.
Publicado: (2019)

Individual cultures of melanoma tumor infiltrating lymphocytes possess distinct patterns of reactivity with mutated antigens identified by whole exome sequencing of autologous tumors
por: Crystal, Jessica S, et al.
Publicado: (2014)

Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer
por: Brito Baleeiro, Renato, et al.
Publicado: (2023)

A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
por: Ni, Qianqian, et al.
Publicado: (2020)

Precision Neoantigen Discovery Using Large-scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation
por: Pyke, Rachel Marty, et al.
Publicado: (2021)

INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery
por: Zhang, Jin, et al.
Publicado: (2017)

Neodb: a comprehensive neoantigen database and discovery platform for cancer immunotherapy
por: Wu, Tao, et al.
Publicado: (2023)

NeoFox: annotating neoantigen candidates with neoantigen features
por: Lang, Franziska, et al.
Publicado: (2021)

Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients
por: Cafri, Gal, et al.
Publicado: (2019)

High frequency CD8+PD-1+ TCR clonotypes isolated from fresh melanomas display anti-tumor activity
por: Anna, Pasetto, et al.
Publicado: (2015)

Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA
por: Chandran, Smita S., et al.
Publicado: (2022)

Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer
por: Liu, Qin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ium63t5ce080ovh4et6m7f959